Synthesis of l-cysteine-based boron compounds and their evaluation as proteasome inhibitors

New Journal of Chemistry

Volumn 38, Issue 10, 2014, Pages 4859-4871

  Milani, Priscila ^a   Demasi, Marilene ^b   De Rezende, Leandro ^a   Amaral, Antonia T Do ^a   Andrade, Leandro H ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b INSTITUTO BUTANTAN   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

3 (BENZYLTHIO) 2 PIVALAMIDO N [3 (4,4,5,5 TETRAMETHYL 1,3,2 DIOXABOROLAN 2 YL)PHENYL]PROPANAMIDE; 3 (BENZYLTHIO) N (3 IODOPHENYL) 2 PIVALAMIDOPROPANAMIDE; 3 [3 (BENZYLTHIO) 2 (METHOXYCARBONYLAMINO)PROPANAMIDO]PHENYLBORONIC ACID; 3 [3 (BENZYLTHIO) 2 (TERT BUTOXYCARBONYLAMINO)PROPANAMIDO]PROPYLBORONIC ACID; AMIDE; BORON DERIVATIVE; BORONIC ACID DERIVATIVE; BORTEZOMIB; CYSTEINE; ESTER DERIVATIVE; LACTACYSTINE; METHYL 3 (BENZYLTHIO) 1 (3 IODOPHENYLAMINO) 1 OXOPROPAN 2 YLCARBAMATE; METHYL 3 (BENZYLTHIO) 1 OXO 1 [3 (4,4,5,5 TETRAMETHYL 1,3,2 DIOXABOROLAN 2 YL)PHENYLAMINO]PROPAN 2 YLCARBAMATE; N [3 (BENZYLTHIO) 1 (3 IODOPHENYLAMINO) 1 OXOPROPAN 2 YL)PYRAZINE 2 CARBOXAMIDE; N [3 (BENZYLTHIO) 1 OXO 1 [4 (4,4,5,5 TETRAMETHYL 1,3,2 DIOXABOROLAN 2 YL)PHENYLAMINO]PROPAN 2 YL]PYRAZINE 2 CARBOXAMIDE; PROTEASOME; PROTEASOME INHIBITOR; TERT BUTYL 1 (ALLYLAMINO) 3 (BENZYLTHIO) 1 OXOPROPAN 2 YLCARBAMATE; TERT BUTYL 3 (BENZYLTHIO) 1 (3 BROMOPHENYLAMINO) 1 OXOPROPAN 2 YLCARBAMATE; TERT BUTYL 3 (BENZYLTHIO) 1 (3 IODOPHENYLAMINO) 1 OXOPROPAN 2 YLCARBAMATE; TERT BUTYL 3 (BENZYLTHIO) 1 (4 BROMOPHENYLAMINO) 1 OXOPROPAN 2 YLCARBAMATE; TERT BUTYL 3 (BENZYLTHIO) 1 (4 IODOPHENYLAMINO) 1 OXOPROPAN 2 YLCARBAMATE; TERT BUTYL 3 (BENZYLTHIO) 1 OXO 1 [3 (4,4,5,5 TETRAMETHYL 1,3,2 DIOXABOROLAN 2 YL)PHENYLAMINO]PROPAN 2 YLCARBAMATE; TERT BUTYL 3 (BENZYLTHIO) 1 OXO 1 [3 (4,4,5,5 TETRAMETHYL 1,3,2 DIOXABOROLAN 2 YL)PROPYLAMINO]PROPAN 2 YLCARBAMATE; TERT BUTYL 3 (BENZYLTHIO) 1 OXO 1 [4 (4,4,5,5 TETRAMETHYL 1,3,2 DIOXABOROLAN 2 YL)PHENYLAMINO]PROPAN 2 YLCARBAMATE; TERT BUTYL 3 (METHYLTHIO) 1 (3 IODOPHENYLAMINO) 1 OXOPROPAN 2 YLCARBAMATE; TERT BUTYL 3 (METHYLTHIO) 1 OXO 1 [3 (4,4,5,5 TETRAMETHYL 1,3,2 DIOXABOROLAN 2 YL)PHENYLAMINO]PROPAN 2 YLCARBAMATE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL ASSAY; CELL LYSATE; CONTROLLED STUDY; DRUG CONFORMATION; DRUG SCREENING; DRUG SYNTHESIS; ENZYME ACTIVITY; ENZYME INHIBITION; FIBROBLAST; IC50; IN VITRO STUDY; MOLECULAR MODEL; MOUSE; NONHUMAN; PHARMACOPHORE; SWISS WEBSTER MOUSE; WHOLE CELL;

EID: 84907853278     PISSN: 11440546     EISSN: 13699261     Source Type: Journal    
DOI: 10.1039/c4nj00612g     Document Type: Article

References (52)

1. A. L. Goldberg J. F. Dice Annu. Rev. Biochem. 1974 43 835 869
2. A. L. Goldberg A. C. St. John Annu. Rev. Biochem. 1976 45 747 803
3. A. Ciechanover EMBO J. 1998 17 7151 7160
4. K. L. Rock A. L. Goldberg Annu. Rev. Immunol. 1999 17 739 779
5. S. Prösch C. Priemer C. Höflich C. Liebenthal N. Babel D. H. Krüger H.-D. Volk Antiviral Ther. 2003 8 555 567
6. W. E. Mitch A. L. N. Goldberg N. Engl. J. Med. 1996 335 1897 1905
7. R. Y. Hampton R. G. Gardner J. Rine Mol. Biol. Cell 1996 7 2029 2044
8. Y. Murakami S. Matsufuji T. Kameji S. Hayashi K. Igarashi T. Tamura K. Tanaka A. Ichihara Nature 1992 360 597 599
9. G. C. Turner F. Du A. Varshavsky Nature 2000 405 579 583
10. N. Naidoo W. Song M. Hunter-Ensor A. Sehgal Science 1999 285 1737 1741
11. D. G. Chain J. H. Schwartz A. N. Hegde Mol. Neurobiol. 1999 20 125 142
12. D. Voges P. Zwickl W. Baumeister Annu. Rev. Biochem. 1999 68 1015 1068
13. O. Coux K. Tanaka A. L. Goldberg Annu. Rev. Biochem. 1996 65 801 847
14. L. Borissenko M. Groll Chem. Rev. 2007 107 687 717
15. G. Nalepa M. Rolfe J. W. Harper Nat. Rev. Drug Discovery 2006 5 596 613
16. M. Groll R. Huber L. Moroder J. Pept. Sci. 2009 15 58 66
17. A. Rentsch D. Landsberg T. Brodmann L. Bülow A.-K. Girbig M. Kalesse Angew. Chem., Int. Ed. 2013 52 5450 5488
18. Y. Zhu S. Yao B. Xu Z. Ge J. Cui T. Cheng R. Li Bioorg. Med. Chem. 2009 17 6851 6861
19. C. N. Papandreou D. D. Daliani D. Nix H. Yang T. Madden X. Wang C. S. Pien R. E. Millikan S. M. Tu L. Pagliaro J. Kim J. Adams P. Elliott D. Esseltine A. Petrusich P. Dieringer C. Perez C. J. Logothetis J. Clin. Oncol. 2004 22 2108 2121
20. J. C. Cusack Cancer Treat. Rev. 2003 29 21 30
21. D. Chauhan T. Hideshima K. C. Anderson Annu. Rev. Pharmacol. Toxicol. 2005 45 465 476
22. W. Yang X. Gao B. Wang Med. Res. Rev. 2003 23 346 368
23. M. Demasi A. L. Felicio A. O. Pacheco H. G. Leite C. Lima L. H. Andrade J. Braz. Chem. Soc. 2010 21 299 305
24. L. Piovan P. Milani M. S. Silva P. G. Moraes M. Demasi L. H. Andrade Eur. J. Med. Chem. 2014 73 280 285
25. L. Piovan L. Wu Z.-Y. Zhang L. H. Andrade Org. Biomol. Chem. 2011 9 1347 1351
26. L. Piovan M. F. M. Alves L. Juliano D. Bromme R. L. O. R. Cunha L. H. Andrade J. Braz. Chem. Soc. 2010 21 2108 2118
27. L. Piovan M. F. M. Alves L. Juliano D. Bromme R. L. O. R. Cunha L. H. Andrade Bioorg. Med. Chem. 2011 19 2009 2014
28. G. Massiot K. Koerber-Plé J. Heterocycl. Chem. 1995 32 1309 1315
29. N. Miyaura T. Ishiyama M. Murata J. Org. Chem. 1995 60 7508 7510
30. C. A. Hutton C. Kardiman T. E. Pennington Tetrahedron Lett. 2004 45 6657 6660
31. G. Fenteany S. L. Schreiber J. Biol. Chem. 1998 273 8545 8548
32. J. Adams M. Behnke C. Chen A. A. Cruickshank L. R. Dick L. Greiner J. M. Klunder Y.-T. Ma L. Plamondon R. L. Stein Bioorg. Med. Chem. Lett. 1998 8 333 338
33. P. Knochel J. Davidson C. E. Tucker J. Org. Chem. 1992 57 3482 3485
34. Adapted from R. A. Copeland, Evaluation of Enzyme Inhibitors in Drug Discovery, John Wiley & Sons, 2005
35. M. Groll Y. Koguchi R. Huber J. Kohno J. Mol. Biol. 2001 311 543 548
36. M. Groll C. R. Berkers H. L. Ploegh H. Ovaa Structure 2006 14 451 456
37. M. Groll R. Huber B. C. M. Potts J. Am. Chem. Soc. 2006 128 5136 5141
38. G. Loidl M. Groll H.-J. Musiol R. Huber L. Moroder Proc. Natl. Acad. Sci. U. S. A. 1999 96 5418 5422
39. M. Groll M. Götz M. Kaiser E. Weyher L. Moroder Chem. Biol. 2006 13 607 614
40. M. Groll K. A. McArthur V. R. Macherla R. R. Manam B. C. Potts J. Med. Chem. 2009 52 5420 5428
41. G. Jones P. Willett R. C. Glen A. T. Leach R. Taylor J. Mol. Biol. 1997 267 727 748
42. GOLD, version 3.0, The Cambridge Crystallographic Data Centre, Cambridge, U.K., 2006
43. M. A. Williams and J. E. Ladbury, Hydrogen Bonds in Protein-Ligand Complexes, in Protein-Ligand Interactions: From Molecular Recognition to Drug Design, ed., H.-J. Böhm, and, G. Schneider, Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim, FRG, 2005
44. C. Bissantz B. Kuhn M. Stahl J. Med. Chem. 2010 53 5061 5084
45. R. A. Laskowski M. B. Swindells J. Chem. Inf. Model. 2011 51 2778 2786
46. T. Scior A. Bender G. Tresadern J. L. Medina-Franco K. Martínez-Mayorga T. Langer K. Cuanalo-Contreras D. K. Agrafiotis J. Chem. Inf. Model. 2012 52 867 1078
47. G. Wolber A. A. Dornhofer T. Langer J. Comput.-Aided Mol. Des. 2007 20 773 788
48. G. Wolber T. Langer J. Chem. Inf. Model. 2005 45 160 169
49. L. Terfloth and J. Gasteiger, Electronic Screening: Lead Finding from Database Mining, in The Practice of Medicinal Chemistry, ed., C. G. Wermuth, Elsevier, Amsterdam, NL, 2nd edn, 2003
50. P. C. D. Hawkins A. G. Skillman G. L. Warren B. A. Ellingson M. T. Stahl J. Chem. Inf. Model. 2010 50 572 584
51. M. Demasi R. Shringarpure K. J. A. Davies Arch. Biochem. Biophys. 2001 389 254 263
52. M. Demasi G. M. Silva L. E. S. Netto J. Biol. Chem. 2003 278 679 685